IL13RA2 and neoplasm: We found that there was a delay in the tumor growth of IL13Rα2-depleted MIV-Luc cells compared with controls and that this was attributed predominantly to a significant, albeit modest, reduction during days 12–16 post-injection (Fig. 3a, b).